New Molecular Sensor Research Could Lead to Earlier Cancer Detection

A new research effort by the National Institute of Standards and Technology (NIST) could improve early cancer detection using mirror-image molecular sensors inspired by the natural symmetry found in human senses. According to NIST, this approach uses DNA and carbon nanotubes to detect subtle differences in molecules, potentially making it easier to spot early indicators of disease, including cancer, in blood samples. The technology builds on the concept of chirality—where molecules are “left-” or “right-handed”—which plays a critical role in biological processes and disease development.

Developed by NIST researcher Ming Zheng and collaborator Ruojie Sha of New York University, the new system leverages two types of DNA—D-DNA and its mirror image L-DNA—combined with twisted carbon nanotubes. These components create paired sensors that mimic human binocular or binaural perception. The dual sensors respond differently to molecules depending on their chirality, which provides a clearer signal than traditional single-sensor methods. The researchers hope this stereo-like detection could produce detailed molecular “fingerprints” that identify specific health markers when interpreted through AI tools.

If proven effective in clinical settings, this method could make diagnostic testing more precise and accessible, especially for identifying early stages of cancer that often go undetected by current tools. The technology also holds promise for uncovering other medical conditions influenced by molecular structures. While still in development, the team at NIST is working on expanding the platform with various sensor pairs to analyze increasingly complex molecules.

The work adds to ongoing efforts to improve molecular measurement tools that aid in medical imaging and diagnostics. Prior projects led by Zheng explored carbon nanotube-based detection of ovarian cancer, which demonstrated higher accuracy than standard procedures. The stereo sensing approach now takes this a step further, enhancing sensitivity to chirality—a molecular feature closely linked to disease. With continued collaboration and technical refinement, the team believes this innovation could support broader applications in public health and early disease intervention.

Article by multiple contributors, based upon information from the National Institute of Standards and Technology press release.

---